Stay updated on Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page.

Latest updates to the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for a mesothelioma immunotherapy and hyperthermia study is now displayed, including its terminated status and detailed study information. Previously, the page showed a 403 Forbidden error.SummaryDifference41%

- Check13 days agoChange DetectedThe site revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces updates to NIH websites and explains that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer’s site revision number changed from v3.7.1 to v3.7.2, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer’s revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and footer, indicating that access to the study details is blocked.SummaryDifference17%

Stay in the know with updates to Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page.